Reducing the Use of Sedative medication in aged care facilities: Implementation of the ‘RedUSe’ project into everyday practice.
Completed
- Conditions
- overuse of psychotropic agents in older residents of residential aged care facilities
- Registration Number
- ACTRN12617001257358
- Lead Sponsor
- niversity of Tasmania
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does ACTRN12617001257358's RedUSe project reduce antipsychotic and benzodiazepine use in aged care?
What molecular mechanisms underlie antipsychotic and benzodiazepine overuse in elderly dementia patients?
Which biomarkers predict successful deprescribing of psychotropic agents in ACTRN12617001257358's aged care study?
What adverse events are linked to antipsychotic and benzodiazepine reduction in ACTRN12617001257358's trial?
How do non-pharmacological alternatives compare to antipsychotics in managing agitation in ACTRN12617001257358's aged care?